Long-Term Outcomes of Patients with Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disease Following Solid Organ Transplant or Allogeneic Hematopoietic Cell Transplant Treated with Tabelecleucel in a Multicenter Expanded Access Program Study

請用此 Handle URI 來引用此文件： http://scholars.ntou.edu.tw/handle/123456789/1332

標題:	Long-Term Outcomes of Patients with Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disease Following Solid Organ Transplant or Allogeneic Hematopoietic Cell Transplant Treated with Tabelecleucel in a Multicenter Expanded Access Program Study
作者:	Prockop, S. E. Reshef, R. Tsai, D. E. Bunin, N. Abu-Arja, R. Mahadeo, K. M. Wen-Kai Weng van Besien, K. Loeb, D. Nasta, S. D. Nemecek, E. R. Hiremath, M. Yue, S. Sun, Y. Navarro, W. H. Nikiforow, S.
公開日期:	三月-2020
卷:	26
期:	3
來源出版物:	Biology of Blood and Marrow Transplantation
URI:	http://scholars.ntou.edu.tw/handle/123456789/1332
ISSN:	1083-8791
DOI:	://WOS:000516887900082
顯示於：	河海工程學系

顯示文件完整紀錄

上周
0

上個月
0

checked on 2022/10/13

檢查

TAIR相關文章